In the context of ocular pharmacology, Brimonidine can lead to which of the following conditions?

Brimonidine is an alpha-2 adrenergic agonist primarily used in the management of glaucoma. One of its notable side effects is the potential to cause follicular conjunctivitis. This condition is characterized by the formation of follicular lesions in the conjunctiva, which can lead to symptoms such as redness and irritation of the eyes. The reason for this side effect is related to the drug's formulation and its preservatives, which can elicit a hypersensitivity reaction in some individuals.

While Brimonidine is expected to lower intraocular pressure effectively, it must be understood that its impact on ocular surface health can lead to adverse effects like conjunctivitis. This highlights the importance of monitoring for such reactions when prescribing this medication. Understanding these potential side effects is crucial for maintaining patient safety and ensuring effective treatment outcomes in ocular pharmacology.